DNA
Ginkgo Bioworks Holdings, Inc.
$9.04
-0.01 (-0.11%)
At close · Jul 14
Market Cap
$587.92M
Shares
65,324,491
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-12 | 2026-06-11 | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-29 | 2026-06-11 | |
| 8-K | 2026-04-07 | 2026-04-03 | |
| Investor Event Transcript | 2026-03-31 | — | |
| 8-K | 2026-02-27 | 2026-02-26 | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2025-12-23 | 2025-12-18 | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-09-04 | — | |
| 8-K | 2025-08-29 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-06-13 | 2025-06-12 | |
| 8-K | 2025-05-21 | 2025-05-19 | |
| 8-K | 2025-05-06 | — | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| DEF 14A | 2025-04-29 | 2025-06-12 | |
| 10-K | 2025-02-25 | 2024-12-31 | |
| 8-K | 2025-02-25 | — | |
| 8-K | 2024-11-12 | 2024-11-06 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-09-04 | 2024-09-03 | |
| 8-K | 2024-08-19 | — | |
| 8-K | 2024-08-15 | 2024-08-14 | |
| 8-K/A | 2024-08-08 | 2024-05-09 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| DEF 14A | 2024-07-05 | 2024-08-14 | |
| 8-K/A | 2024-06-24 | 2024-05-09 | |
| 8-K | 2024-06-14 | 2024-06-13 | |
| 8-K | 2024-05-13 | 2024-05-07 | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-29 | 2024-06-13 | |
| 8-K | 2024-03-14 | 2024-03-08 | |
| 10-K | 2024-02-29 | 2023-12-31 | |
| 8-K | 2024-02-29 | — | |
| 8-K | 2024-01-10 | — | |
| 10-Q | 2023-11-08 | 2023-09-30 | |
| 8-K | 2023-11-08 | — | |
| 8-K | 2023-10-27 | — | |
| 8-K | 2023-10-03 | — | |
| 8-K | 2023-08-29 | — | |
| 8-K | 2023-08-23 | — | |
| 10-Q | 2023-08-09 | 2023-06-30 | |
| 8-K | 2023-08-09 | — | |
| 8-K | 2023-06-20 | 2023-06-16 |
Showing 1–50 of 93 filings